NPS Pharmaceuticals Inc (NPSP.OQ)

NPSP.OQ on NASDAQ Stock Exchange Global Select Market

4:00pm EDT
Price Change (% chg)

$0.43 (+1.47%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for NPSP.OQ


NPS Pharmaceuticals, Inc. (NPS) is a biopharmaceutical company focused on pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide. The Company’s primary product Gattex 0.05 mg/kg/d (teduglutide [rDNA origin]) for injection, for subcutaneous use was approved by the United States Food... (more)


Beta: 0.70
Market Cap (Mil.): $3,114.30
Shares Outstanding (Mil.): 106.33
Dividend: --
Yield (%): --


  NPSP.OQ Industry Sector
P/E (TTM): -- 99.85 35.92
EPS (TTM): -0.13 -- --
ROI: -6.23 -0.25 18.26
ROE: -24.30 -1.05 19.14
Search Stocks

Shire secures $5 billion funding for NPS Pharma bid: The Times

- London-listed drugmaker Shire Plc has secured a $5 billion credit facility for a takeover offer for New-Jersey-based NPS Pharmaceuticals, The Times of London reported on Sunday.

01 Jun 2014

Shire considering bid for NPS Pharmaceuticals - FT

LONDON, May 30 - London-listed drugmaker Shire is considering a bid for New Jersey-based NPS Pharmaceuticals, FT Alphaville reported on Friday citing sources.

30 May 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: Sadif Analytics (Premium)

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks